如何实施FAPI PET:一项快速系统评价,为使用不同FAPI示踪剂的FAPI PET显像提供推荐
本快速系统评价检索PubMed、Embase、Cochrane Library与Web of Science(2023年4月),纳入159项使用FAPI示踪剂的同行评议队列研究,按示踪剂分组汇总扫描流程。最常用为[68Ga]Ga-FAPI-04(98项,61%)与[68Ga]Ga-FAPI-46(19项,12%);多数机构给药80-200 MBq、注射后60分钟扫描,[68Ga]Ga-FAPI-46的现有证据支持早于30分钟采集的可行性。
要点
- 多数研究采用[68Ga]Ga-FAPI-04/46、给药80-200 MBq、注射后60分钟扫描。
- [68Ga]Ga-FAPI-46现有证据一致支持早于30分钟采集图像的可行性。
- 3项研究显示[68Ga]Ga-FAPI-46在10分钟与更晚时间点肿瘤检出等效,仅靶本比略低。
核心结论
- 尽管范围较宽,多数机构给予平均80-200 MBq的[68Ga]Ga-FAPI-04/46并在注射后60分钟扫描患者。
- 对于[68Ga]Ga-FAPI-46,现有证据一致支持早于30分钟采集图像的可行性。
- 目前关于最佳FAPI PET扫描流程的数据有限,鼓励开展更多研究;本综述可作为计划开展FAPI PET研究的机构的临时指南。
研究设计与样本
- 研究类型为快速系统评价,检索PubMed、Embase、Cochrane Library与Web of Science数据库,检索时间为2023年4月。
- 纳入英文同行评议、使用FAPI示踪剂的队列研究;关键扫描流程信息缺失或30天内无法从大学图书馆获取的文章被排除。
- 共识别946条记录,筛选后纳入159项研究;因预试验结果认为不适合进行统计学Meta分析,数据按所用FAPI示踪剂分组。
- [68Ga]Ga-FAPI-04应用于98项研究(61%),其次为[68Ga]Ga-FAPI-46,共19项研究(12%)。
关键影像表现/征象
- 多数研究未报告具体的患者准备。
- 平均/中位给药活度以80-200 MBq最常见,但[68Ga]Ga-FAPI-04 PET研究的范围较宽(56-370 MBq)。
- 所有FAPI PET研究中注射至扫描时间以60分钟为主;[68Ga]Ga-FAPI-46观察到注射至扫描时间可能趋向更短。
- 3项研究在超过593个癌症病灶中评估了[68Ga]Ga-FAPI-46 PET多时间点采集,10分钟与更晚时间点的肿瘤检出均等效,尽管靶本比略低。
临床应用与阅片要点
- 本综述可作为计划开展FAPI PET研究的机构的临时指南。
- 对于[68Ga]Ga-FAPI-46,现有证据一致支持早于30分钟采集图像的可行性。
- 目前关于最佳FAPI PET扫描流程的数据有限,鼓励开展更多研究。
局限性
- 目前关于最佳FAPI PET扫描流程的数据有限。
- 鼓励开展更多研究。
- 基于预试验,认为不适合进行统计学Meta分析。
- 多数研究未报告具体的患者准备。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
This expedited systematic review aims to provide the first overview of the different Fibroblast activation protein inhibitor (FAPI) PET scan procedures in the literature and discuss how to efficiently obtain optimal FAPI PET images based on the best available evidence. The PubMed, Embase, Cochrane Library, and Web of Science databases were systematically searched in April 2023. Peer-reviewed cohort studies published in English and used FAPI tracers were included. Articles were excluded if critical scan procedure information was missing, or the article was not retrievable from a university library within 30 days. Data were grouped according to the FAPI tracer applied. Meta-analysis with proper statistics was deemed not feasible based on a pilot study. A total of 946 records were identified. After screening, 159 studies were included. [68Ga]Ga-FAPI-04 was applied in 98 studies (61%), followed by [68Ga]Ga-FAPI-46 in 19 studies (12%). Most studies did not report specific patient preparation. A mean/median administered activity of 80-200 MBq was most common; however, wide ranges were seen in [68Ga]Ga-FAPI-04 PET studies (56-370 MBq). An injection-to-scan-time of 60 minutes was dominant for all FAPI PET studies. A possible trend toward shorter injection-to-scan times was observed for [68Ga]Ga-FAPI-46. Three studies evaluated [68Ga]Ga-FAPI-46 PET acquisition at multiple time points in more than 593 cancer lesions, all yielding equivalent tumor detection at 10 minutes vs later time points despite slightly lower tumor-to-background Ratios. Despite the wide ranges, most institutions administer an average of 80-200 MBq [68Ga]Ga-FAPI-04/46 and scan patients at 60 minutes postinjection. For [68Ga]Ga-FAPI-46, the present evidence consistently supports the feasibility of image acquisition earlier than 30 minutes. Currently, data on the optimal FAPI PET scan procedure are limited, and more studies are encouraged. The current review can serve as a temporary guideline for institutions planning FAPI PET studies.
引用
- Bentestuen M, Nalliah S, Stolberg MMK, et al. How to Perform FAPI PET? An Expedited Systematic Review Providing a Recommendation for FAPI PET Imaging With Different FAPI Tracers. Semin Nucl Med. 2023. PMID: 38052711. doi:10.1053/j.semnuclmed.2023.11.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。